The authors of a 2016 analysis of MDMA, published from the Journal of Psychopharmacology, concluded that the drug “provides a promising procedure for PTSD.”” By the early eighties, even so, it was circulating while in the upmarket nightclubs of Big apple and Dallas, where it was described variously as a new rival to copyright and as “the yu